Colin Rom is currently Managing Director of Science and Innovation Policy at Mayo Clinic. The portfolio includes issues related to regulatory and policy landscapes facing Mayo Clinic Labs, Ventures, Platform, , Research and Mayo Clinic’s Cancer Center. Prior to Mayo, Colin served as the Senior Advisor to Commissioner Stephen Hahn at the U.S. Food & Drug Administration and also spent a year in FDA’s office of policy managing agency-wide initiatives around drug pricing, innovation and advanced manufacturing. Before FDA, Colin worked for a year at the White House Office of Management and Budget helping to manage, develop and negotiate the federal healthcare budget and spent five years in the U.S. Senate including two years on the Senate HELP Committee working on life sciences policy.